HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Beatriz Amorena Selected Research

Infections

11/2017Characterization of Ovine A3Z1 Restriction Properties against Small Ruminant Lentiviruses (SRLVs).
1/2016Post-entry blockade of small ruminant lentiviruses by wild ruminants.
4/2015Diagnosing infection with small ruminant lentiviruses of genotypes A and B by combining synthetic peptides in ELISA.
11/2014In vivo monitoring of Staphylococcus aureus biofilm infections and antimicrobial therapy by [18F]fluoro-deoxyglucose-MicroPET in a mouse model.
8/2013Immunization against small ruminant lentiviruses.
4/2012The extradomain a of fibronectin enhances the efficacy of lipopolysaccharide defective Salmonella bacterins as vaccines in mice.
3/2012The extradomain A of fibronectin (EDA) combined with poly(I:C) enhances the immune response to HIV-1 p24 protein and the protection against recombinant Listeria monocytogenes-Gag infection in the mouse model.
7/2011Use of small ruminant lentivirus-infected rams for artificial insemination.
2/2011Immunological parameters in goats experimentally infected with SRLV genotype E, strain Roccaverano.
2/2011Identification of the ovine mannose receptor and its possible role in Visna/Maedi virus infection.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Beatriz Amorena Research Topics

Disease

17Infections
11/2017 - 01/2002
2Osteomyelitis
07/2006 - 01/2002
1Latent Infection
11/2014
1Arthritis (Polyarthritis)
05/2012
1Pneumonia (Pneumonitis)
05/2012
1Virus Diseases (Viral Diseases)
02/2011
1Visna
10/2009
1of Sheep Progressive Interstitial Pneumonia (Maedi)
10/2009
1Asymptomatic Infections
12/2007
1Mastitis
11/2004
1Staphylococcal Infections
06/2002

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
11/2017 - 06/2002
3VaccinesIBA
03/2012 - 07/2005
3AntigensIBA
03/2012 - 12/2007
2Mannose ReceptorIBA
05/2012 - 02/2011
2DNA (Deoxyribonucleic Acid)IBA
07/2011 - 07/2005
1Antiviral Agents (Antivirals)IBA
11/2017
1Interferon-gamma (Interferon, gamma)IBA
11/2017
1Neutralizing AntibodiesIBA
01/2016
1Peptides (Polypeptides)IBA
04/2015
1Rifampin (Rifampicin)FDA LinkGeneric
11/2014
1Deoxyglucose (2 Deoxy D glucose)IBA
11/2014
1AIDS VaccinesIBA
08/2013
1Bacterial VaccinesIBA
04/2012
1StreptavidinIBA
04/2012
1Fibronectins (Fibronectin)IBA
03/2012
1B-Lymphocyte Epitopes (B-Cell Epitope)IBA
03/2012
1Poly I-CIBA
03/2012
1EpitopesIBA
03/2012
1Messenger RNA (mRNA)IBA
07/2011
1Viral ProteinsIBA
07/2011
1dUTP pyrophosphataseIBA
02/2011
1Concanavalin AIBA
02/2011
1MannansIBA
02/2011
1env Gene ProductsIBA
02/2011
1RNA (Ribonucleic Acid)IBA
12/2007
1CytokinesIBA
07/2006
1Interleukin-6 (Interleukin 6)IBA
07/2006
1Anti-Bacterial Agents (Antibiotics)IBA
07/2006
1Interleukin-10 (Interleukin 10)IBA
07/2006
1Interleukin-1 (Interleukin 1)IBA
07/2006
1DNA VaccinesIBA
07/2005
1Membrane Proteins (Integral Membrane Proteins)IBA
11/2004
1CalciumIBA
11/2004
1VancomycinFDA LinkGeneric
12/2002
1Stainless Steel (Steel, Stainless)IBA
01/2002
1SuspensionsIBA
01/2002

Therapy/Procedure

2Therapeutics
11/2014 - 01/2002
1Orthopedic Procedures
01/2002